Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1993 Nov;52(11):835–836. doi: 10.1136/ard.52.11.835-b

Effect of hormone replacement therapy on markers of bone metabolism in RA.

W F Lems, H R van den Brink, M I Gerrits, H J van Rijn, J W Bijlsma
PMCID: PMC1005200  PMID: 8250618

Full text

PDF
835

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Elomaa I., Virkkunen P., Risteli L., Risteli J. Serum concentration of the cross-linked carboxyterminal telopeptide of type I collagen (ICTP) is a useful prognostic indicator in multiple myeloma. Br J Cancer. 1992 Aug;66(2):337–341. doi: 10.1038/bjc.1992.266. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hassager C., Fabbri-Mabelli G., Christiansen C. The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen. Osteoporos Int. 1993 Jan;3(1):50–52. doi: 10.1007/BF01623177. [DOI] [PubMed] [Google Scholar]
  3. Kröger H., Risteli J., Risteli L., Penttilä I., Alhava E. Serum osteocalcin and carboxyterminal propeptide of type I procollagen in rheumatoid arthritis. Ann Rheum Dis. 1993 May;52(5):338–342. doi: 10.1136/ard.52.5.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Melkko J., Niemi S., Risteli L., Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem. 1990 Jul;36(7):1328–1332. [PubMed] [Google Scholar]
  5. Nilas L., Christiansen C. The pathophysiology of peri- and postmenopausal bone loss. Br J Obstet Gynaecol. 1989 May;96(5):580–587. doi: 10.1111/j.1471-0528.1989.tb03260.x. [DOI] [PubMed] [Google Scholar]
  6. Risteli J., Elomaa I., Niemi S., Novamo A., Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem. 1993 Apr;39(4):635–640. [PubMed] [Google Scholar]
  7. van den Brink H. R., Lems W. F., van Everdingen A. A., Bijlsma J. W. Adjuvant oestrogen treatment increases bone mineral density in postmenopausal women with rheumatoid arthritis. Ann Rheum Dis. 1993 Apr;52(4):302–305. doi: 10.1136/ard.52.4.302. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES